Remove companies emergent-biosolutions-inc
article thumbnail

Bavarian To Buy Emergent BioSolutions Vaccines For $380M

Law 360 M&A

Danish biotechnology company Bavarian Nordic AS said Wednesday it will acquire three travel vaccines and related assets from U.S. rival Emergent BioSolutions Inc. for $380 million, in a deal guided by Cooley LLP and Barnes & Thornburg LLP.

40
article thumbnail

Gibson Dunn Offers 2022 Mid-Year Securities Litigation Update

Reynolds Holding

Lucia Companies, Inc. Lee Enterprises, Inc. CytoDyn Inc. 13, 2021), which we discussed in our 2021 Year-End Securities Litigation Update, the court declined to apply both the stringent review of Blasius Industries, Inc. UIP Companies, Inc. Chris-Craft Industries, Inc. , Atlas Corp. ,